BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31308149)

  • 1. Semaphorin 4C Promotes Macrophage Recruitment and Angiogenesis in Breast Cancer.
    Yang J; Zeng Z; Qiao L; Jiang X; Ma J; Wang J; Ye S; Ma Q; Wei J; Wu M; Huang X; Ma D; Gao Q
    Mol Cancer Res; 2019 Oct; 17(10):2015-2028. PubMed ID: 31308149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.
    Gurrapu S; Pupo E; Franzolin G; Lanzetti L; Tamagnone L
    Cell Death Differ; 2018 Jul; 25(7):1259-1275. PubMed ID: 29555978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated Lymphatic Endothelial Cells Promote Lymphatic Metastasis By Highly Expressing and Secreting SEMA4C.
    Wei JC; Yang J; Liu D; Wu MF; Qiao L; Wang JN; Ma QF; Zeng Z; Ye SM; Guo ES; Jiang XF; You LY; Chen Y; Zhou L; Huang XY; Zhu T; Meng L; Zhou JF; Feng ZH; Ma D; Gao QL
    Clin Cancer Res; 2017 Jan; 23(1):214-224. PubMed ID: 27401250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
    Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
    J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 4C regulates ovarian steroidogenesis through RHOA/ROCK1-mediated actin cytoskeleton rearrangement.
    Chen D; Wu C; Wei S; Guo Y; Wu M; Zhou S; Fu F; Tang W; Xue L; Zhang J; Li Y; Dai J; Li Y; Ye S; Wang S
    Mol Hum Reprod; 2023 Apr; 29(5):. PubMed ID: 36892447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.
    Smeester BA; Slipek NJ; Pomeroy EJ; Bomberger HE; Shamsan GA; Peterson JJ; Crosby MR; Draper GM; Becklin KL; Rahrmann EP; McCarthy JB; Odde DJ; Wood DK; Largaespada DA; Moriarity BS
    Oncogene; 2020 Jan; 39(5):1049-1062. PubMed ID: 31582836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development.
    Maier V; Jolicoeur C; Rayburn H; Takegahara N; Kumanogoh A; Kikutani H; Tessier-Lavigne M; Wurst W; Friedel RH
    Mol Cell Neurosci; 2011 Feb; 46(2):419-31. PubMed ID: 21122816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
    Lin F; Xie YJ; Zhang XK; Huang TJ; Xu HF; Mei Y; Liang H; Hu H; Lin ST; Luo FF; Lang YH; Peng LX; Qian CN; Huang BJ
    J Exp Clin Cancer Res; 2019 Apr; 38(1):152. PubMed ID: 30961661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages.
    Seoane S; Martinez-Ordoñez A; Eiro N; Cabezas-Sainz P; Garcia-Caballero L; Gonzalez LO; Macia M; Sanchez L; Vizoso F; Perez-Fernandez R
    J Pathol; 2019 Nov; 249(3):381-394. PubMed ID: 31292963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
    Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
    J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells.
    Gurrapu S; Franzolin G; Fard D; Accardo M; Medico E; Sarotto I; Sapino A; Isella C; Tamagnone L
    Sci Signal; 2019 Aug; 12(595):. PubMed ID: 31431542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of SEMA4C Inhibit Epithelial-Mesenchymal Transition (EMT) and the Invasion and Metastasis of Cervical Cancer Cells via Inhibiting Transforming Growth Factor-beta 1 (TGF-β1)-Induced Hela cells p38 Mitogen-Activated Protein Kinase (MAPK) Activation.
    Yang L; Yu Y; Xiong Z; Chen H; Tan B; Hu H
    Med Sci Monit; 2020 Jan; 26():e918123. PubMed ID: 31951596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling.
    Rego SL; Helms RS; Dréau D
    Angiogenesis; 2014 Jul; 17(3):573-85. PubMed ID: 24197832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
    Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
    Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages.
    Sierra JR; Corso S; Caione L; Cepero V; Conrotto P; Cignetti A; Piacibello W; Kumanogoh A; Kikutani H; Comoglio PM; Tamagnone L; Giordano S
    J Exp Med; 2008 Jul; 205(7):1673-85. PubMed ID: 18559453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.
    Hou Y; Wang W; Zeng Z; Gan W; Lv S; Li T; Yan Z; Zhang R; Yang M
    Aging (Albany NY); 2020 Nov; 12(21):21992-22018. PubMed ID: 33177246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer.
    Lin L; Chen YS; Yao YD; Chen JQ; Chen JN; Huang SY; Zeng YJ; Yao HR; Zeng SH; Fu YS; Song EW
    Oncotarget; 2015 Oct; 6(33):34758-73. PubMed ID: 26416449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.
    Datar I; Qiu X; Ma HZ; Yeung M; Aras S; de la Serna I; Al-Mulla F; Thiery JP; Trumbly R; Fan X; Cui H; Yeung KC
    Oncotarget; 2015 Nov; 6(36):39050-61. PubMed ID: 26375811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.